Iterative Health
Latest round
- Series C
Last raised
- Apr 2026
Total raised
- $271M
Investors
- 14
About Iterative Health
Based in the US, Iterative Scopes, Inc. specializes in transforming gastrointestinal (GI) care through innovative healthcare technology, leveraging AI solutions to enhance diagnostics and improve patient outcomes. Founded in 2017 and headquartered in Cambridge, US, Iterative Scopes, Inc. focuses on advancing gastrointestinal healthcare. Iterative Health specializes in advanced healthcare technology and services aimed at transforming gastrointestinal (GI) care. The company’s core offerings include AI-powered solutions that optimize clinical trial processes, enhance diagnostics, and improve patient care. Their flagship product, SKOUT, provides real-time AI support for colorectal cancer screening and surveillance, empowering physicians to deliver timely interventions. Iterative Health serves a diverse client base, including clinical research sites, healthcare professionals, and life sciences organizations, primarily across the United States and Europe. By focusing on these geographical markets, the company aims to address pressing challenges in GI care and expand access to innovative therapeutics, ultimately improving patient outcomes. Iterative Health’s revenue model primarily revolves around partnerships and collaborations with clinical trial sponsors and research sites. This structure typically involves B2B transactions, where healthcare organizations utilize Iterative Health’s technology and services to enhance their research capabilities and patient care offerings. Clients benefit from subscription-based access to their unique products, including SKOUT, which facilitates efficient colorectal cancer screening and surveillance. While specific pricing plans for individual services are not publicly disclosed, the company’s focus on optimizing clinical trials and providing advanced diagnostics positions it to secure sustained revenue growth through ongoing partnerships with biopharmaceutical companies and research institutions. Iterative Scopes, Inc. The company is focused on developing new AI-driven solutions aimed at improving the efficiency of GI care.
Who invested in Iterative Health
14 investors across 5 rounds
See all investors in Iterative Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Iterative Health
Who invested in Iterative Health?
Iterative Health has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Iterative Health raised?
Iterative Health has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Iterative Health last raise money?
Iterative Health's most recent round on record is a Series C, in Apr 2026.
What does Iterative Health do?
Based in the US, Iterative Scopes, Inc.
Where is Iterative Health headquartered?
Iterative Health is headquartered in Cambridge, US.
Which VCs invest in companies like Iterative Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Iterative Health's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Iterative Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.